Ikarian Capital, LLC - Nov 30, 2025 SCHEDULE 13G/A Report for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: TENX
Shares outstanding: 6.24M shares
Disclosed Ownership: 968K shares
Ownership: 15.5%
Form type: SCHEDULE 13G/A
Date filed: 12/5/2025, 04:51 PM
Date of event: Nov 30, 2025
Previous filing: Oct 7, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	15.5%	968K	0	968K	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	15.5%	968K	0	968K	/s/ Neil Shahrestani	Neil Shahrestani